GlyCosmos Glycolipids
Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
| Database | Last Updated |
|---|---|
| ChEBI | February 3, 2022 |
| KEGG | February 3, 2022 |
| LIPID MAPS Structure Database | February 3, 2022 |
| LipidBank | February 3, 2022 |
| PubChem | February 3, 2022 |
| Main Class | Sub Class | LM ID | Common Name | LipidBank ID | KEGG ID | PubChem CID ▲ | ChEBI ID | Exact Mass | Formula |
|---|---|---|---|---|---|---|---|---|---|
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
Para-Forssman x3b(d18:1/26:0)
|
1569.985817
|
C78H143N3O28
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
Para-Forssman x3b(d18:1/24:1(15Z))
|
1539.938867
|
C76H137N3O28
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
Para-Forssman x3b(d18:1/26:1(17Z))
|
1567.970167
|
C78H141N3O28
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
SSEA-3 antigen(d18:1/16:0)
|
1388.802768
|
C66H120N2O28
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
SSEA-3 antigen(d18:1/18:0)
|
1416.834068
|
C68H124N2O28
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
SSEA-3 antigen(d18:1/20:0)
|
1444.865368
|
C70H128N2O28
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
SSEA-3 antigen(d18:1/22:0)
|
1472.896668
|
C72H132N2O28
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
SSEA-3 antigen(d18:1/24:0)
|
1500.927968
|
C74H136N2O28
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
SSEA-3 antigen(d18:1/26:0)
|
1528.959268
|
C76H140N2O28
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
SSEA-3 antigen(d18:1/24:1(15Z))
|
1498.912318
|
C74H134N2O28
|
Displaying entries 161 - 170 of 3908 in total
International Collaboration
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Acknowledgements
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
